Medicaid Expansion and Stage at Diagnosis, Timely Initiation and Receipt of Guideline-Concordant Treatment, and Survival Among People With Non–Small Cell Lung Cancer

A study published in the Journal of Clinical Oncology examined the impact of Medicaid expansion on outcomes for patients with non-small cell lung cancer (NSCLC). The research assessed whether expanded insurance coverage led to earlier-stage diagnoses, more timely treatment initiation, greater adherence to guideline-concordant therapy, and improved survival. The findings contribute to the growing body of evidence linking health insurance policy to cancer outcomes and disparities. This work is particularly relevant given ongoing debates about healthcare access and its tangible effects on cancer survival in the United States.